Myocarditis after Covid-19 mRNA Vaccination
| Errataetall: |
CommentIn: Travel Med Infect Dis. 2021 Nov-Dec;44:102164. - PMID 34534685 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:385 |
|---|---|
| Enthalten in: |
The New England journal of medicine - 385(2021), 14 vom: 30. Sept., Seite 1332-1334 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Verma, Amanda K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2019-nCoV Vaccine mRNA-1273 |
|---|
| Anmerkungen: |
Date Completed 18.10.2021 Date Revised 07.12.2021 published: Print-Electronic CommentIn: Travel Med Infect Dis. 2021 Nov-Dec;44:102164. - PMID 34534685 Citation Status MEDLINE |
|---|
| doi: |
10.1056/NEJMc2109975 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329508512 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329508512 | ||
| 003 | DE-627 | ||
| 005 | 20231225205253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMc2109975 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1098.xml |
| 035 | |a (DE-627)NLM329508512 | ||
| 035 | |a (NLM)34407340 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Verma, Amanda K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Myocarditis after Covid-19 mRNA Vaccination |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.10.2021 | ||
| 500 | |a Date Revised 07.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Travel Med Infect Dis. 2021 Nov-Dec;44:102164. - PMID 34534685 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 650 | 7 | |a 2019-nCoV Vaccine mRNA-1273 |2 NLM | |
| 650 | 7 | |a EPK39PL4R4 |2 NLM | |
| 650 | 7 | |a BNT162 Vaccine |2 NLM | |
| 650 | 7 | |a N38TVC63NU |2 NLM | |
| 700 | 1 | |a Lavine, Kory J |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Chieh-Yu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 385(2021), 14 vom: 30. Sept., Seite 1332-1334 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
| 773 | 1 | 8 | |g volume:385 |g year:2021 |g number:14 |g day:30 |g month:09 |g pages:1332-1334 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMc2109975 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 385 |j 2021 |e 14 |b 30 |c 09 |h 1332-1334 | ||